NASDAQ · Biotechnology

Iovance Biotherapeutics Inc (IOVA)

$8.48 -11.30%
Add alert See all oversold stocks →
30 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$5.07+67.26%

Company profile

Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.

SectorHealthcare
IndustryBiotechnology
Market cap$6.50B
P/E ratioNone
EPS$-0.69
Beta0.757
Dividend yield0.00%
52-week high$15.30
52-week low$1.76

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IBRX ImmunityBio Inc RSI 44 BMRN Biomarin Pharmaceutical Inc RSI 55 TECH Bio-Techne Corp RSI 57 VKTX Viking Therapeutics Inc RSI 48 TARS Tarsus Pharmaceuticals Inc RSI 55 ATAI ATAI Life Sciences N.V. RSI 62 MRVI Maravai LifeSciences Holdings Inc - Class A RSI 54
30 days of PRO Unlimited free, no card

RSI alerts for IOVA

An email when IOVA closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 8:55 PM EDT